Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cells

Cardiovascular Research

Volumn 46, Issue 1, 2000, Pages 172-179

  Ying, Anita K ^a   Hassanain, Hamdy H ^a   Roos, Christine M ^a   Smiraglia, Dominic J ^b   Issa, Jean Pierre J ^c   Michler, Robert E ^a   Caligiuri, Michael ^b   Plass, Christoph ^b   Goldschmidt Clermont, Pascal J ^a  

^a Davis Heart and Lung Research Institute   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Artherosclerosis; Receptors; Smooth muscle

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENOME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SMOOTH MUSCLE FIBER;

AORTA; BLOTTING, SOUTHERN; CELL DIVISION; CELL LINE; CELLS, CULTURED; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RESTRICTION MAPPING;

EID: 0034060168     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00004-3     Document Type: Article

References (48)

1. Antequera F., Bird A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA. 90:1993;11995-11999.
2. Bird A. The essentials of DNA methylation. Cell. 70:1992;5-8.
3. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature. 321:1986;209-213.
4. Mohandas T., Sparkes R.S., Shapiro L.J. CpG-rich islands and the function of DNA methylation. Science. 211:1981;393-396.
5. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
6. Issa J.P., Baylin S.B., Herman J.G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia. 11:(Suppl 1):1997;S7-11.
7. Herman J.G., Merlo A., Mao L., et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:1995;4525-4530.
8. Merlo A., Herman J.G., Mao L., et al. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:1995;686-692.
9. Herman J.G., Latif F., Weng Y., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91:1994;9700-9704.
10. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 7:1994;536-540.
11. Ottaviano Y.L., Issa J.P., Parl F.F., Smith H.S., Baylin S.B., Davidson N.E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54:1994;2552-2555.
12. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1994;1501-1510.
13. Issa J.P., Zehnbauer B.A., Civin C.I., et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res. 56:1996;973-977.
14. Schwartz S.M., Campbell G.R., Campbell J.H. Replication of smooth muscle cells in vascular disease. Circ. Res. 58:1986;427-444.
15. Campbell G.R., Campbell J.H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp. Mol. Pathol. 42:1985;139-162.
16. Chamley-Campbell J., Campbell G.R., Ross R. The smooth muscle cell in culture. Physiol. Rev. 59:1979;1-61.
17. Schwartz S.M., deBlois D., O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77:1995;445-465.
18. Seidel C.L. Cellular heterogeneity of the vascular tunica media. Implications for vessel wall repair. Arterioscler. Thromb. Vasc. Biol. 17:1997;1868-1871.
19. Sullivan T.R., Karas R.H., Aronovitz M., et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96:1995;2482-2488.
20. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. New Engl J Med. 340:1999;1801-1811.
21. Fischer-Dzoga K., Wissler R.W., Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp. Mol. Pathol. 39:1983;355-363.
22. Vargas R., Wroblewska B., Rego A., Hatch J., Ramwell P.W. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br. J. Pharmacol. 109:1993;612-617.
23. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc. 280:1998;605-613.
24. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 43:1999;985-991.
25. Warnecke P.M., Stirzaker C., Melki J.R., Millar D.S., Paul C.L., Clark S.J. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids. Res. 25:1997;4422-4426.
26. Wang R.Y., Gehrke C.W., Ehrlich M. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids. Res. 8:1980;4777-4790.
27. Okazaki Y., Okuizumi H., Sasaki N., et al. An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8). Electrophoresis. 16:1995;197-202.
28. Plass C., Shibata H., Kalcheva I., et al. Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat. Genet. 14:1996;106-109.
29. Hayashizaki Y., Hirotsune S., Okazaki Y., et al. Restriction landmark genomic scanning method and its various applications. Electrophoresis. 14:1993;251-258.
30. Xiong Z., Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids. Res. 25:1997;2532-2534.
31. Frommer M., McDonald L.E., Millar D.S., et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA. 89:1992;1827-1831.
32. Lapidus R.G., Nass S.J., Butash K.A., et al. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res. 58:1998;2515-2519.
33. Jones P.A. DNA methylation errors and cancer. Cancer Res. 56:1996;2463-2467.
34. Laird P.W., Jaenisch R. DNA methylation and cancer. Hum. Mol. Genet. 3:1994;1487-1495.
35. Jones P.A., Wolkowicz M.J., Rideout W.M., et al. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. USA. 87:1990;6117-6121.
36. Plass C., Weichenhan D., Catanese J., et al. An arrayed human not I-EcoRV boundary library as a tool for RLGS spot analysis. DNA Res. 4:1997;253-255.
37. Plass C., Yu F., Yu L., Strout M.P., El-Rifai W., Elonen E., Knuutila S., Marcucci G., Young D.C., Held W.A., Bloomfield C.D., Caligiuri M.A. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene. 18:1999;3159-3165.
38. McClintok B. The discovery and characterization of transposable elements. 1987;Garland, New York.
39. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA. 70:1973;1753-1756.
40. Murry C.E., Gipaya C.T., Bartosek T., Benditt E.P., Schwartz S.M. Monoclonality of smooth muscle cells in human atherosclerosis. Am. J. Pathol. 151:1997;697-705.
41. Sartore S., Chiavegato A., Franch R., Faggin E., Pauletto P. Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease. Arterioscler. Thromb. Vasc. Biol. 17:1997;1210-1215.
42. Kockx M.M., De Meyer G.R., Jacob W.A., Bult H., Herman A.G. Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler. Thromb. 12:1992;1447-1457.
43. Clowes A.W., Schwartz S.M. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56:1985;139-145.
44. Campbell G.R., Campbell J.H., Manderson J.A., Horrigan S., Rennick R.E. Arterial smooth muscle. A multifunctional mesenchymal cell. Arch. Pathol. Lab. Med. 112:1988;977-986.
45. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 50:1971;172-186.
46. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:1998;141-196.
47. Rousseau F., Bonaventure J., Legeai-Mallet L., et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371:1994;252-254.
48. Schwartz S.M., Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49:1998;437-460.